New drug delivery system aims to increase tissue penetration
Improved efficacy and dosing convenience are the aims of a new drug delivery system incorporating a cationic polymer and formulated with ketorolac.
New data confirm efficacy, safety of ranibizumab
New data presented at the European Society of Retina Specialists meeting suggest that ranibizumab is effective in patients with AMD, DME, and RVO.
Encourage patients with bilateral vision loss to be more active
Newly published research gives ophthalmologists a reason to encourage their adult patients with visual field loss in both eyes to be more physically active.
Editor's Blog: Ophthalmologists from around the world come to learn
Mark Dlugoss, Ophthalmology Times editor-in-chief, is blogging daily from ESCRS. Today he discusses the attendance of Latin American physicians at ESCRS.
Editor's Blog: The year of intraocular lenses (IOLs)
Ophthalmology Times editor-in-chief, Mark Dlugoss, is blogging daily from ESCRS. Today he discusses various releases of intraocular lenses (IOLs).
Editor's Blog: ESCRS grown to become a unique ophthalmic meeting
Ophthalmology Times Editor-in-Chief, Mark Dlugoss, blogs daily from the 2012 congress of the European Society of Cataract and Refractive Surgeons (ESCRS).
Cause of cone death discovered in retinitis pigmentosa
Researchers have identified the mode of death of cone photoreceptor cells in an animal model of retinitis pigments (RP).
Wilmer Eye Institute awarded AHAF grants for glaucoma and AMD
Glaucoma and age-related macular degeneration (AMD) research grants have been awarded to Wilmer Eye Institute by the American Health Assistance Foundation.
Welch Allyn facility earns LEED environmental certification
The Welch Allyn facility in Beaverton, OR, earned Leadership in Energy and Environmental Design (LEED) certification from the U.S. Green Building Council.
Moore named Iridex interim president, CEO
William M. Moore has been named interim president and chief executive officer of Iridex Corp. Moore succeeds Dominik Beck.
STAAR Surgical consolidates lens operations in Monrovia, CA
Implantable contact lens and preloaded IOL manufacturing will move to California in a consolidation project now under way at STAAR Surgical.
Glaucoma may be linked to depression
Glaucoma may be a significant predictor of depression, according to research published in the American Journal of Ophthalmology.
FDA clears laser for cataract surgery incisions
The FDA approved OptiMedica's Catalys Precision for creating single-plane and multi-plane arc incisions in the cornea during cataract surgery.
Trifocal diffractive intraocular lens reduces spectacle dependency
A trifocal diffractive intraocular lens (FineVision IOL, PhysIOL) reduces spectacle dependence after cataract surgery and provides patient satisfaction.
Phase II study for travoprost punctum plugs
Ocular Therapeutix Inc. is initiating a phase II clinical trial of OTX-TP2, a 2-month travoprost punctum plug for treating ocular hypertension and glaucoma.
Allergan, Molecular Partners enter DARPin agreements
Allergan Inc. and Molecular Partners AG have entered into two agreements to discover, develop, and commercialize proprietary therapeutic designed ankyrin repeat protein (DARPin) products for the treatment of opthalmic diseases.
Gevokizumab receives orphan drug designation
Gevokizumab, an IL-1 beta-modulating antibody from XOMA Corp., has received FDA orphan drug designation for the treatment of several types of non-infectious uveitis.
Laser surgery education gets $1 million boost
Ophthalmologists will have a new way to learn about advances in laser surgery next year, thanks to a $1 million donation made to the American Academy of Ophthalmology.
Share tips with patients during Cataract Awareness Month
Educating the public about cataract risk factors, detection, and treatment options has been the goal of the American Academy of Ophthalmology (AAO) EyeSmart program during August, Cataract Awareness Month.
Retinal disease research gets $2.4 million boost
The Foundation Fighting Blindness is funding projects related to age-related macular degeneration, retinitis pigmentosa, Leber's congenital amaurosis, and Usher syndrome.
Fibrin glue may cause TASS
Fibrin glue might be a potential cause of toxic anterior segment syndrome (TASS).
Accomodative changes in the ACD less pronounced in high myopia
A study found that accommodative changes in the central anterior chamber depth (ACD) of patients with high myopia were less pronounced than emmetropic eyes.
VICTUS femtosecond laser in action (VIDEO), capsulotomy creation
A short video of capsulotomy creation with the VICTUS femtosecond laser.
Allergan and Molecular Partners enter two new agreements
Allergan and Molecular Partners AG have expanding their relationship with two new agreements for DARPin products.
JCAHPO taps Pearson VUE to offer simulated exams
The Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) and Pearson VUE partner to provide ophthalmic medical techs access to simulated exams.
Insight Software ranked on Inc. 500|5000 list
Insight Software, creators of My Vision Express, has been ranked by Inc. magazine as one of the nation's fastest-growing private companies.
Enrollment begins for cataract surgery pain trial
Patient enrollment has begun in a phase III clinical trial of a low dose of bromfenac for pain and inflammation reduction after cataract surgery.
September is Sports Eye Injury Awareness Month
Prevent Blindness America (PBA) has designated September as Sports Eye Safety Awareness Month.
Ophthalmologists fare relatively well in survey of physician burnout, work/life balance
Compared to an average of all physicians, ophthalmologists fared slightly better in a survey of physician burnout.
Retinal prosthesis on track for further testing
The 256+ channel Boston subretinal prosthesis is on track for in vivo validation of function and an FDA investigational device exemption application.
